Finance entity
Of the tracked stories, 1 of 2 also mention Collegium Pharmaceutical, Inc., the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.6 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 6.3 in the same window.
Last mentioned: Jul 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 1 of 2 also mention Collegium Pharmaceutical, Inc., the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.6 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. markets accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Truist Securities appears in 2 tracked Finance stories published from March 15, 2026 through March 19, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 530 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Truist Securities. Shared-story counts are live from our verified record — not editorial picks.
Eventide Rebalancing
Eventide Asset Management reports a reduced but significant stake of $83.65 million in Collegium.
Institutional Reduction
Integrated Quantitative Investments LLC reduces its stock position in COLL.
Truist Analysis
Truist Securities highlights momentum for Jornay PM and a robust pain portfolio.
BDSI Acquisition
Collegium completes the acquisition of BioDelivery Sciences International, adding Belbuca to its portfolio.
Truist Securities has lowered its price target for Community Healthcare Trust (CHCT) while maintaining a positive outlook on the company's long-term growth trajectory. The adjustment follows a recent earnings miss but underscores confidence in the REIT's specialized non-urban healthcare portfolio.
Source: finance.yahoo.com · insidermonkey.com
Eventide Asset Management LLC has reduced its equity position in Collegium Pharmaceutical, Inc. (COLL), though it maintains a significant $83.65 million stake. This institutional shift comes as the specialty pharmaceutical firm navigates a shifting landscape for chronic pain management and expands into neurology.
Truist Securities is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
